RHUMBLINE ADVISERS - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 174 filers reported holding THERAPEUTICSMD INC in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$119,000
+12.3%
312,526
+4.8%
0.00%
Q4 2021$106,000
-53.1%
298,154
-2.2%
0.00%
Q3 2021$226,000
-33.3%
304,989
+7.0%
0.00%
Q2 2021$339,000
-20.8%
285,109
-10.8%
0.00%
-100.0%
Q1 2021$428,000
+20.2%
319,606
+8.7%
0.00%
Q4 2020$356,000
-32.4%
294,108
-11.9%
0.00%
-100.0%
Q3 2020$527,000
+10.9%
333,812
-12.1%
0.00%0.0%
Q2 2020$475,000
+57.8%
379,921
+33.7%
0.00%0.0%
Q1 2020$301,000
-58.8%
284,245
-5.8%
0.00%0.0%
Q4 2019$730,000
-30.0%
301,643
+5.0%
0.00%
-50.0%
Q3 2019$1,043,000
+42.9%
287,199
+2.2%
0.00%
+100.0%
Q2 2019$730,000
-37.4%
280,961
+17.3%
0.00%
-50.0%
Q1 2019$1,166,000
+27.4%
239,465
-0.3%
0.00%0.0%
Q4 2018$915,000
-12.0%
240,143
+51.5%
0.00%0.0%
Q3 2018$1,040,000
+1.0%
158,497
-4.0%
0.00%0.0%
Q2 2018$1,030,000
+35.5%
165,138
+5.8%
0.00%0.0%
Q1 2018$760,000
-17.8%
156,076
+2.0%
0.00%0.0%
Q4 2017$925,000
-5.9%
153,081
-17.6%
0.00%0.0%
Q3 2017$983,000
+1.7%
185,788
+1.3%
0.00%0.0%
Q2 2017$967,000
-24.2%
183,408
+3.5%
0.00%
-33.3%
Q1 2017$1,276,000
+32.1%
177,176
+5.8%
0.00%
+50.0%
Q4 2016$966,000
-11.2%
167,481
+4.9%
0.00%
-33.3%
Q3 2016$1,088,000
-18.6%
159,694
+1.6%
0.00%
-25.0%
Q2 2016$1,336,000
+49.4%
157,154
+12.5%
0.00%
+33.3%
Q1 2016$894,000
-31.9%
139,650
+10.4%
0.00%
-25.0%
Q4 2015$1,312,000
+101.8%
126,505
+14.0%
0.00%
+100.0%
Q3 2015$650,000
-22.5%
110,950
+3.9%
0.00%
-33.3%
Q2 2015$839,000
+28.3%
106,759
-1.2%
0.00%
+50.0%
Q1 2015$654,000
+81.2%
108,024
+33.0%
0.00%
+100.0%
Q4 2014$361,000
-0.8%
81,224
+3.6%
0.00%0.0%
Q3 2014$364,000
+8.7%
78,399
+3.3%
0.00%0.0%
Q2 2014$335,000
-17.9%
75,899
+17.3%
0.00%0.0%
Q1 2014$408,000
+14.3%
64,685
-5.5%
0.00%0.0%
Q4 2013$357,000
+79.4%
68,485
+1.0%
0.00%0.0%
Q3 2013$199,000
-3.9%
67,795
-0.9%
0.00%0.0%
Q2 2013$207,00068,4000.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q4 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders